Browsing by Author Amaral S

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 5 of 5
Publication DateTitleAuthor(s)TypeSubject
10-Nov-2021Estimation of scabies prevalence using simplified criteria and mapping procedures in three Pacific and southeast Asian countries.Tsoi SK; Lake SJ; Thean LJ; Matthews A; Sokana O; Kama M; Amaral S; Romani L; Whitfeld M; Francis JR; Vaz Nery S; Marks M; Kaldor JM; Steer AC; Engelman DJournal Article- 
16-Sep-2022Gastrointestinal Carriage of Antimicrobial Resistance in School-Aged Children in Three Municipalities of Timor-Leste.Oakley T; Le B; da Conceicao V; Marr I; Maia C; Soares M; Belo JC; Sarmento N; da Silva E; Amaral S; Vaz Nery S; Lynar S; Francis JR; Yan JJournal Article- 
27-Nov-2021Integrated serological surveillance of acute febrile illness in the context of a lymphatic filariasis survey in Timor-Leste: a pilot study using dried blood spots.Arkell P; Angelina J; do Carmo Vieira A; Wapling J; Marr I; Monteiro M; Matthews A; Amaral S; da Conceicao V; Kim SH; Bailey D; Yan J; Fancourt's NSS; Vaz Nery S; Francis JRJournal Article- 
15-Mar-2021Prevalence of scabies and impetigo in school-age children in Timor-Leste.Matthews A; Le B; Amaral S; Arkell P; Monteiro M; Clarke N; Barros T; de Jesus Mendonça J; Gusmão SME; Dos Reis Seixas LM; da Piedade JHA; Engelman D; Steer AC; Fancourt NSS; Yan J; Kaldor, John; Francis JR; Nery SVJournal Article- 
May-2023Vaccine Preventable Disease Seroprevalence in a Nationwide Assessment of Timor-Leste (VASINA-TL): study protocol for a population-representative cross-sectional serosurvey.Arkell P; Sheridan S; Martins N; Tanesi M; Gomes N; Amaral S; Oakley T; Solano V; David M; Draper A; Sarmento N; da Silva E; Alves L; Freitas C; Machado F; Gusmão C; da Costa Barreto I; Fancourt N; Macartney K; Yan J; Francis JJournal ArticleHumans; Seroepidemiologic Studies; Timor-Leste/epidemiology; Cross-Sectional Studies; *Vaccine-Preventable Diseases; *COVID-19/epidemiology/prevention & control; SARS-CoV-2; Immunoglobulin G; Northern Territory 
Showing results 1 to 5 of 5